Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03261479 · ClinicalTrials.gov registry record

Validation of Thermal Imaging to Detect Pneumonia

A clinical trial, sponsored by Massachusetts General Hospital.

Terminated
Registry status
22
Enrollment target

NCT03261479: Clinical Trial study, sponsored by Massachusetts General Hospital.

NCT03261479 is a clinical trial that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03261479 was terminated before completion, sponsored by Massachusetts General Hospital.

TERMINATED
Registry status
22 participants
Enrollment target

Study Summary

The investigators are proposing a two-stage, prospective, cohort study of 138 subjects \> 28 days old and \< 18 years old with respiratory distress, already getting a chest x-ray as part of their routine clinical care, who will get thermal pictures of their chest at the Massachusetts General Hospital (MGH) Emergency Department, Pediatric Wards, and Pediatric Intensive Care Unit. The thermal cameras will measure skin temperature, by taking a picture, in a non-contact way. The investigators will recruit 138 patients using the FLIR ONE thermal imaging camera for iPhone and the newly designed irPNA application. The FLIR ONE thermal imaging camera will be attached to a study-designated iPhone which will only have the ability to take pictures. This phone will not have the capability to make calls or use the internet. The iPhone will be password protected, as encrypted by Partners regulations. Demographic and diagnostic data will be collected from patient charts.

Primary Outcome

Compare identification of pneumonia in thermal image to x-rays read by study radiologists

Interventions

  • DIAGNOSTIC_TEST Thermal image

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2016-04-13
Est. Completion 2020-06-01
Massachusetts General Hospital

2,032 total trials

Why NCT03261479 stopped before completion

NCT03261479 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Thermal image is the first listed.

NCT03261479 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03261479 about?

NCT03261479 is a clinical study titled "Validation of Thermal Imaging to Detect Pneumonia". The investigators are proposing a two-stage, prospective, cohort study of 138 subjects \> 28 days old and \< 18 years old with respiratory distress, already getting a chest x-ray as part of their routine clinical care, who will get thermal pictures of their chest at the Massachusetts General Hospita...

What is the current status of trial NCT03261479?

This trial is currently terminated. The enrollment target is 22 participants. The study started on 2016-04-13. Estimated completion is 2020-06-01.

What interventions are being tested in trial NCT03261479?

The interventions under investigation include: Thermal image (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03261479?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03261479, the US trial registry maintained by the National Library of Medicine. NCT03261479 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.